# Beta Bionics (BBNX): value investors who own it | moatshark

0 value investors held Beta Bionics in their Q3 2026 13F. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| First Eagle Investment Management | 0.0% | $0k | Sold out | 3 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-10-14 | Hopman Mark | Chief Commercial Officer | Sold | 775 | $13k |
| 2026-10-01 | Hopman Mark | Chief Commercial Officer | Sold | 370 | $7k |
| 2026-09-22 | Jones Christy | Director | Sold | 6430 | $148k |
| 2026-09-16 | Hopman Mark | Chief Commercial Officer | Sold | 30779 | $620k |
| 2026-09-16 | Mensinger Mike | Chief Product Officer | Sold | 2650 | $58k |
| 2026-09-14 | Hopman Mark | Chief Commercial Officer | Sold | 775 | $12k |
| 2026-09-09 | Hopman Mark | Chief Commercial Officer | Sold | 36870 | $681k |
| 2026-09-03 | Saint Sean | President & CEO | Sold | 5641 | $113k |
| 2026-09-02 | Saint Sean | President & CEO | Sold | 16867 | $322k |
| 2026-09-02 | Feider Stephen | Chief Financial Officer | Sold | 6675 | $128k |
| 2026-09-02 | Hopman Mark | Chief Commercial Officer | Sold | 5327 | $102k |
| 2026-09-02 | Mensinger Mike | Chief Product Officer | Sold | 4375 | $84k |
| 2026-09-02 | Russell Steven Jon | Chief Medical Officer | Sold | 4221 | $81k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/bbnx). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.